SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-18-000030
Filing Date
2018-08-09
Accepted
2018-08-09 16:49:48
Documents
110
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-06x30x201810qdoc.htm 10-Q 1914924
2 EXHIBIT 3.1 exhibit312restatedcertific.htm EX-3.1 95639
3 EXHIBIT 3.2 exhibit322bylawsofamneal.htm EX-3.2 147399
4 EXHIBIT 10.8 amrx-06x30x2018x10qxex108i.htm EX-10.8 205789
5 EXHIBIT 31.1 ceo.htm EX-31.1 24700
6 EXHIBIT 31.2 cfo.htm EX-31.2 22830
7 EXHIBIT 32.1 amrx-06x30x2018x10qxex321s.htm EX-32.1 10165
8 EXHIBIT 32.2 amrx-06x30x2018x10qxex322x.htm EX-32.2 9322
  Complete submission text file 0001723128-18-000030.txt   12028021

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ipxl-20180630.xml EX-101.INS 2588938
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ipxl-20180630.xsd EX-101.SCH 80080
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ipxl-20180630_cal.xml EX-101.CAL 147268
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ipxl-20180630_def.xml EX-101.DEF 458917
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ipxl-20180630_lab.xml EX-101.LAB 1060223
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ipxl-20180630_pre.xml EX-101.PRE 665122
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 181006016
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences